Cercar
01/02/2025
Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society
Pedro-Botet, J, Arrieta, F, Botana, M, Gimeno-Orna, JA, Martinez-Montoro, JI, de Victoria, EOM, Ribalta, J, Sánchez-Margalet, V, Pérez-Pérez, A. Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society. Endocrinologia Diabetes y Nutricion. 2025; 72(2)DOI:10.1016/j.endien.2025.101523. PMID:39924389. IF:1.800(Q3/8D).
30/01/2025
Expert consensus on vitamin D in osteoporosis
Lei, S, Zhang, XY, Song, LG, Wen, JH, Zhang, Z, Tian, JQ, Yang, R, Xu, SH, Qiu, SH, Macisaac, RJ, Aleksova, J, Mac-Way, F, Dupuis, ME, Benaiges, D, Mauricio, D, Sommer, AP, Barzilay, JI, Gallagher, JC, Pan, LL, Ji, LL, Fang, P, Li, Y, Liu, Q, Zhao, JS, Xue, Y, Shen, YQ, Wang, LM, Han, JF, Liu, GH. Expert consensus on vitamin D in osteoporosis. Annals Of Joint. 2025; 10DOI:10.21037/aoj-24-48. PMID:39981430. IF:(Q/D).
15/02/2024
Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies.
Genua I, Cusi K. Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies.. Diabetes Spectrum : A Publication Of The American Diabetes Association. 2024; 37(1)DOI:10.2337/dsi23-0012. PMID:38385098. IF:(Q/D).
01/02/2022
Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
Gil, J, Marques-Pamies, M, Valassi, E, Garcia-Martinez, A, Serra, G, Hostalot, C, Fajardo-Montanana, C, Carrato, C, Bernabeu, I, Marazuela, M, Rodriguez-Lloveras, H, Camara, R, Salinas, I, Lamas, C, Biagetti, B, Simo-Servat, A, Webb, SM, Pico, A, Jorda, M, Puig-Domingo, M. Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response. Biomedicines. 2022; 10(2)DOI:10.3390/biomedicines10020460. PMID:35203668. IF:4.700(Q1/3D).